MCHP MICROCHIP TECHNOLOGY INC
Semiconductors & Related Devices · Nasdaq · SEC CIK 827054 · Fiscal year ends 03/31
Financial factors as of 2026-09-30 (2027Q2), TTM = sum of the last four quarters
Growth
TTM revenue YoY33.0%
TTM net income YoY552.8%
TTM EPS YoY395.6%
Revenue 3-yr CAGR-14.4%
Net income 3-yr CAGR-30.7%
Margins
Gross margin62.7%
Operating margin20.9%
Net margin15.0%
FCF margin26.0%
EBITDA margin28.1%
Returns
ROE12.6%
ROA5.8%
ROIC (approx.)8.6%
Asset turnover0.38x
Leverage & solvency
Liabilities / assets54.7%
Debt / equity0.83x
Current ratio2.24x
Interest coverage5.75x
Cash quality & payout
Operating cash flow / net income1.82x
Accruals ratio-4.7%
Payout ratio117.8%
Capex / revenue1.3%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20262026-03-31 | FY20252025-03-31 |
|---|---|---|
| Income statement | ||
| Revenue | $4.71B | $4.40B |
| Cost of revenue | $1.99B | $1.93B |
| Gross profit | $2.72B | $2.47B |
| R&D expense | $1.09B | $983.80M |
| SG&A expense | $674.30M | $617.70M |
| Operating income | $490.10M | $296.30M |
| Interest expense | $221.30M | $259.20M |
| Pretax income | $273.50M | $38.90M |
| Income tax | $43.50M | $39.40M |
| Net income | $230.00M | -$500,000 |
| EBITDA | $1.18B | $1.05B |
| EPS (basic) | 0.22 | -0.01 |
| EPS (diluted) | 0.22 | -0.01 |
| Dividends declared per share | 1.82 | 1.82 |
| Weighted avg. shares (diluted) | 545.20M | 537.30M |
| Balance sheet | ||
| Cash & equivalents | $240.30M | $771.70M |
| Receivables | $894.70M | $689.70M |
| Inventory | $1.04B | $1.29B |
| Current assets | $2.38B | $2.99B |
| PP&E, net | $1.11B | $1.18B |
| Goodwill | $6.70B | $6.68B |
| Intangibles | $2.03B | $2.39B |
| Total assets | $14.37B | $15.37B |
| Current liabilities | $1.14B | $1.16B |
| Short-term debt | $0 | $0 |
| Long-term debt | $5.50B | $5.63B |
| Total debt | $5.50B | $5.63B |
| Total liabilities | $7.94B | $8.30B |
| Shareholders' equity | $6.43B | $7.08B |
| Net debt | $5.26B | $4.86B |
| Shares outstanding | 542.08M | 538.70M |
| Cash flow statement | ||
| Operating cash flow | $962.10M | $898.10M |
| Capital expenditure | $91.10M | $126.00M |
| Free cash flow | $871.00M | $772.10M |
| Investing cash flow | -$195.50M | -$287.80M |
| Financing cash flow | -$1.30B | -$158.30M |
| Depreciation & amortization | $689.30M | $750.10M |
| Stock-based compensation | $255.40M | $180.40M |
| Dividends paid | $984.00M | $975.70M |
| Share buybacks | $0 | $96.50M |
Free plan shows the latest 2 periods; Pro shows all 19 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.